European Patent Office

T 0534/07 (CD8 T cells/OXXON THERAPEUTICS) of 25.11.2008

European Case Law Identifier
ECLI:EP:BA:2008:T053407.20081125
Date of decision
25 November 2008
Case number
T 0534/07
Petition for review of
-
Application number
98928434.4
IPC class
C12N 15/30
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Reagents for vaccination which generate a CD8 T cell immune response
Applicant name
Oxxon Therapeutics Limited
Opponent name
Sanofi Pasteur
OXFORD BIOMEDICA (UK) LTD.
Therion Biologics Corporation
POWDERJECT VACCINES INC.
Danisco US Inc
Board
3.3.08
Headnote
-
Keywords
Admissibility of appellant II's appeal - (no) - missing statement of grounds
Admissibility of appellant I's appeal - (yes)
Exclusion of representatives - (no) - no legal basis
Novelty - (yes)
Inventive step - (yes)
Sufficiency of disclosure (yes)
Catchword
-
Citing cases
-

ORDER

For these reasons it is decided that:

1. The appeal filed by the appellant PowderJect Vaccines Inc. is rejected as inadmissible.

2. The request filed by the appellant Danisco US, Inc. that the patent attorneys of Carpmaels and Ransford be excluded from further representing any of the parties in proceedings relating to the patent-in-suit EP 979 284 is rejected.

3. The decision under appeal is set aside.

4. The case is remitted to the opposition division with the order to maintain the patent with the claims of the main request of 24 October 2008, said claims having been filed as "First Auxiliary Request- amended", and a description and drawings to be adapted thereto.